Purple Biotech (PPBT) Cash from Investing Activities Growth (3y) (2020 - 2026)

Purple Biotech (PPBT) Cash from Investing Activities Growth (3y) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (3y) (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 116.52%
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 38.24%
9 Abivax 90.15 Bn 90.15 Bn - -
10 Purple Biotech 242.86 Mn 236.43 Mn - -84.72%

Historic Data

Download Data
DateValue
Mar 31, 2026 -84.72%
Dec 31, 2025 -26.26%
Sep 30, 2025 28.09%
Jun 30, 2025 26.37%
Mar 31, 2025 -75.61%
Dec 31, 2024 -80.42%
Sep 30, 2024 -64.24%
Jun 30, 2024 -74.83%
Mar 31, 2024 -38.06%
Dec 31, 2023 26.02%
Dec 31, 2022 16.73%
Dec 31, 2021 -0.18%
Dec 31, 2020 -140.88%